These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8592019)

  • 1. Genetic counseling for familial cancer risk.
    Weitzel JN
    Hosp Pract (1995); 1996 Feb; 31(2):57-69. PubMed ID: 8592019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: where are we today?
    Cole DE; Gallinger S; McCready DR; Rosen B; Engel J; Malkin D
    CMAJ; 1996 Jan; 154(2):149-55. PubMed ID: 8548703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences from a clinic for patients with hereditary cancer. Diagnosis of genetic carriers may prevent cancer].
    Lindblom A; Iselius L
    Lakartidningen; 1995 May; 92(18):1915-8. PubMed ID: 7746044
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinics for counseling on cancer genetics. Experiences with genetic studies and counseling on familial breast cancer and colorectal cancer].
    Gerdes AM; Rasmussen K; Graversen HP; Kronborg O; Qvist N; Holm NV; Axelsson CK; Rose C; Ahrons S; Dyreborg U; Hørder M
    Ugeskr Laeger; 1998 Feb; 160(8):1145-51. PubMed ID: 9492624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary cancers: from discovery to intervention.
    Knudson AG
    J Natl Cancer Inst Monogr; 1995; (17):5-7. PubMed ID: 8573454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
    Roukos DH; Briasoulis E
    Nat Clin Pract Oncol; 2007 Oct; 4(10):578-90. PubMed ID: 17898808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
    Shulman LP
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: first experiences with patient perceptions, surveillance behavior and acceptance of genetic testing.
    Hofferbert S; Worringen U; Backe J; Rückert EM; White K; Faller H; Grimm T; Caffier H; Chang-Claude J; Weber BH
    Genet Couns; 2000; 11(2):127-46. PubMed ID: 10893664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic risk assessment for breast and ovarian cancer.
    O'Rourke Tiffen J; Pfeifer K; Fishman DA
    Adv Nurse Pract; 2003 Oct; 11(10):40-8. PubMed ID: 14601495
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring family relationships in cancer risk counseling using the genogram.
    Daly M; Farmer J; Harrop-Stein C; Montgomery S; Itzen M; Costalas JW; Rogatko A; Miller S; Balshem A; Gillespie D
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):393-8. PubMed ID: 10207645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using genetic analysis to individualize preventive measures for breast and ovarian cancers.
    Olopade OI
    Nat Clin Pract Oncol; 2006 Apr; 3(4):182-3. PubMed ID: 16596140
    [No Abstract]   [Full Text] [Related]  

  • 13. Hereditary breast and ovarian cancer syndrome.
    ACOG Committee on Practice Bulletins
    Gynecol Oncol; 2009 Apr; 113(1):6-11. PubMed ID: 19309638
    [No Abstract]   [Full Text] [Related]  

  • 14. Scale-up technology: moving predictive tests for inherited breast, ovarian, and colon cancers from the bench to the bedside and beyond.
    Holtzman NA
    J Natl Cancer Inst Monogr; 1995; (17):95-7. PubMed ID: 8573464
    [No Abstract]   [Full Text] [Related]  

  • 15. Hereditary breast and ovarian cancer syndrome: should we test adolescents?
    Seeber B; Driscoll DA
    J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):161-7. PubMed ID: 15125901
    [No Abstract]   [Full Text] [Related]  

  • 16. A sociobehavioural perspective on genetic testing and counselling for heritable breast, ovarian and colon cancer.
    Macdonald KG; Doan B; Kelner M; Taylor KM
    CMAJ; 1996 Feb; 154(4):457-64. PubMed ID: 8630835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
    van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
    Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommendations for treatment of individuals at risk for hereditary breast and ovarian carcinoma].
    Radulović S; Branković-Magić M; Janković R; Ristanović M
    Srp Arh Celok Lek; 2003; 131(7-8):345-50. PubMed ID: 14692152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics: predisposition and management.
    Legare RD
    Clin Obstet Gynecol; 2011 Mar; 54(1):180-90. PubMed ID: 21278518
    [No Abstract]   [Full Text] [Related]  

  • 20. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer.
    Dickens BM; Pei N; Taylor KM
    CMAJ; 1996 Mar; 154(6):813-8. PubMed ID: 8634959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.